Phase II Trial: Thai Cannabis-Based Medicine vs Lorazepam for Insomnia
This Phase II randomized controlled trial evaluates traditional thai cannabis-based medicine for insomnia treatment. The study compares its efficacy and safety against lorazepam. Results provide clinical insights into cannabis-based multi-herbal…
Randomized cannabinoid trial reports improvement in chronic pain outcomes #1
A controlled trial examined cannabinoids and pain-related endpoints in adults with chronic symptoms.
Cannabinoid Sleep Trials: EEG Insomnia Research (2026)
This cannabinoid sleep trials insomnia study used EEG to assess the effects of THC and CBD on sleep in adults with insomnia. The trial found reduced total sleep time and altered REM sleep. These findings highlight the complexity of cannabinoids' impact…
Clinical Research on Endocannabinoid System and Cannabis Trials
This article reviews endocannabinoid system cannabis clinical trial data from recent randomized controlled trials. The research highlights the role of cannabis in mental health and substance use outcomes. These findings provide valuable insights for…
Cannabinoid Clinical Trials for Mental Health: Key Findings
Cannabinoid clinical trials mental health evidence remains limited and inconclusive. Current research does not establish clear efficacy or safety profiles for cannabinoids in mental health treatment. Clinicians should interpret approvals cautiously given…
Cannabinoids for Mental Health: Large Review Finds Mostly Low-Quality Evidence With Few Clear Benefits
The 2026 systematic review on cannabinoids for mental health reveals mostly low-quality evidence with few clear benefits. This comprehensive analysis highlights limited support for cannabinoids in treating mental disorders. More high-quality research is…
Cannabinoids Show Modest, Low-Certainty Benefits for a Few Mental Health Conditions—But Widespread Clinical Use Is Not Justified
This 2026 review examines cannabinoids mental health benefits, revealing modest effects for select conditions. Evidence remains limited and of low certainty. Routine clinical use is not justified without further trials.
The efficacy and safety of cannabinoids for mental and substance use disorders
This review examines cannabinoids for mental substance use disorders evidence, focusing on their efficacy and safety. Mental health and substance use disorders are common reasons for cannabinoid use. The study highlights the need for careful clinical…
Endocannabinoid System Clinical Research: Cannabis Sleep Trial EEG
This article reviews endocannabinoid system sleep clinical RCT evidence involving cannabis in insomnia patients. The study found that a THC and CBD combination reduced total sleep time. These findings emphasize caution and the need for more research on…
Cannabinoids for Pediatric Use: Clinical Evidence Review
Cannabinoids for pediatric use have been studied across various medical conditions in children under 18. This clinical evidence review highlights safety and efficacy data from trials and observational studies. The evolving research landscape supports…